CGTK Corgentech Inc. (MM)

SOUTH SAN FRANCISCO, Calif., Feb. 24 /PRNewswire-FirstCall/ -- Corgentech Inc. (NASDAQ:CGTK), a biotechnology company, today announced that John P. McLaughlin, the company's chief executive officer, will present at the 2006 Citigroup Global Health Care Conference on February 28, 2006 at 9:10 a.m. EST in Washington DC. Mr. McLaughlin will discuss the company's pipeline of pain management and inflammation product candidates and will review the company's projected milestones for 2006. To access the live webcast or the subsequent archived recording, log on to http://www.corgentech.com/ and go to the Investors page, and click on Webcasts. Please connect to Corgentech's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary. About Corgentech Corgentech is a late-stage biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for pain and inflammation. The company has four drug candidates in clinical development for multiple potential indications, the most advanced of which, ALGRX 3268, has completed Phase 3 clinical trials. Corgentech is based in South San Francisco, CA. For more information on the company, please visit http://www.corgentech.com/. DATASOURCE: Corgentech Inc. CONTACT: Jennifer Cook Williams, Vice President, Investor Relations of Corgentech Inc., +1-650-624-9600, or Web site: http://www.corgentech.com/

Copyright